Huangzhen Wang

449 total citations
8 papers, 268 citations indexed

About

Huangzhen Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Huangzhen Wang has authored 8 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Huangzhen Wang's work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Huangzhen Wang is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Huangzhen Wang collaborates with scholars based in China, Georgia and United States. Huangzhen Wang's co-authors include Sida Qin, Xin Sun, Yamei Pang, Guodong Xiao, Yanbo Li, Hong Ren, Jian Liu, Ning Du, Chongwen Xu and Ganghua Yang and has published in prestigious journals such as Cell Cycle, Journal of Cellular and Molecular Medicine and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Huangzhen Wang

8 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huangzhen Wang China 8 225 135 60 26 16 8 268
Evan J. Greenawalt United States 5 234 1.0× 193 1.4× 46 0.8× 25 1.0× 11 0.7× 5 277
Juanfei Peng China 9 218 1.0× 160 1.2× 58 1.0× 42 1.6× 10 0.6× 13 285
Traci Kruer United States 9 176 0.8× 136 1.0× 32 0.5× 17 0.7× 10 0.6× 19 246
Huajun Qu China 9 208 0.9× 176 1.3× 41 0.7× 42 1.6× 12 0.8× 13 247
Yao‐Jie Pan China 10 255 1.1× 190 1.4× 36 0.6× 22 0.8× 16 1.0× 17 319
Xiaojun Man China 9 185 0.8× 115 0.9× 41 0.7× 44 1.7× 14 0.9× 22 244
Edyta Vieth United States 7 267 1.2× 113 0.8× 72 1.2× 38 1.5× 20 1.3× 7 328
Scott Bang United States 6 203 0.9× 120 0.9× 95 1.6× 21 0.8× 8 0.5× 7 273

Countries citing papers authored by Huangzhen Wang

Since Specialization
Citations

This map shows the geographic impact of Huangzhen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huangzhen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huangzhen Wang more than expected).

Fields of papers citing papers by Huangzhen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huangzhen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huangzhen Wang. The network helps show where Huangzhen Wang may publish in the future.

Co-authorship network of co-authors of Huangzhen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Huangzhen Wang. A scholar is included among the top collaborators of Huangzhen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huangzhen Wang. Huangzhen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liu, Jian, Xiang Li, Meng Wang, et al.. (2018). A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer. International Journal of Oncology. 53(4). 1601–1612. 36 indexed citations
2.
Pang, Yamei, Jian Liu, Guodong Xiao, et al.. (2018). MYC and DNMT3A‐mediated DNA methylation represses microRNA‐200b in triple negative breast cancer. Journal of Cellular and Molecular Medicine. 22(12). 6262–6274. 63 indexed citations
3.
Liu, Jian, Xin Sun, Sida Qin, et al.. (2016). CDH1 promoter methylation correlates with decreased gene expression and poor prognosis in patients with breast cancer. Oncology Letters. 11(4). 2635–2643. 50 indexed citations
4.
Zhang, Boxiang, Huangzhen Wang, Yiwen Zhang, et al.. (2016). OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications. Pathology - Research and Practice. 212(10). 893–898. 10 indexed citations
5.
Qin, Sida, Boxiang Zhang, Guodong Xiao, et al.. (2016). Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation. Tumor Biology. 37(10). 13509–13520. 13 indexed citations
6.
Yang, Chengcheng, Huangzhen Wang, Boxiang Zhang, et al.. (2016). LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC. Journal of Experimental & Clinical Cancer Research. 35(1). 158–158. 49 indexed citations
7.
Liu, Jian, Yamei Pang, Huangzhen Wang, et al.. (2016). [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].. PubMed. 32(3). 299–303. 10 indexed citations
8.
Xu, Chongwen, Xin Sun, Sida Qin, et al.. (2015). Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells. Cell Cycle. 14(11). 1686–1697. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026